Search review questions

Quality of life · Adults with symptomatic mild to moderate knee osteoarthritis defined as knee pain and radiographic evidence of non‐end…

Disease response · psoriatic arthritis

Health‐related quality of life ‐ not measured · psoriatic arthritis

Disease activity ‐ not measured · psoriatic arthritis

Radiographic progression ‐ not measured · psoriatic arthritis

Serious adverse events (leflunomide) assessed by number of events · psoriatic arthritis

Withdrawals due to adverse events (leflunomide) assessed by number of events · psoriatic arthritis

Serious adverse events (ciclosporin A) assessed by number of events · psoriatic arthritis

Withdrawals due to adverse events (ciclosporin A) assessed by number of events · psoriatic arthritis

Function · psoriatic arthritis

Health‐related quality of life ‐ not reported · psoriatic arthritis

Disease activity · psoriatic arthritis

Radiographic progression ‐ not measured · psoriatic arthritis

Serious adverse events (SAEs) assessed by number of events · psoriatic arthritis

Withdrawals due to adverse events (WAEs) assessed by number of events · psoriatic arthritis

Disease response (leflunomide) · psoriatic arthritis

Function (leflunomide) · psoriatic arthritis

Knee pain Scale from: 0 to 10 (0 is no pain) · adult participants with patellar tendinopathy

Participant global assessment of success Scale from: 0 to 100 (higher is greater satisfaction) · adult participants with patellar tendinopathy

Quality of life · adult participants with patellar tendinopathy

Withdrawal rate · adult participants with patellar tendinopathy

Adverse event · adult participants with patellar tendinopathy

Tendon rupture · adult participants with patellar tendinopathy

Function Scale from: 0 to 100 (100 is best function) · adult participants with patellar tendinopathy

Participant global assessment of success (People who perceived their pain as none) · adult participants with patellar tendinopathy

Quality of life · adult participants with patellar tendinopathy

Withdrawal rate · adult participants with patellar tendinopathy

Adverse event · adult participants with patellar tendinopathy

Tendon rupture · adult participants with patellar tendinopathy

Knee pain Scale from: 0 to 100 (0 is no pain) · adult participants with patellar tendinopathy

Function · adult participants with patellar tendinopathy

Mean change in pain (0–100 scale) Short term (3–12 weeks), where 0 = no pain · people with hip or knee osteoarthritis

Physical function (WOMAC function 0–100) · people with hip or knee osteoarthritis

Quality of life Not measured · people with hip or knee osteoarthritis

Withdrawals due to adverse events 24 weeks · people with hip or knee osteoarthritis

Total adverse events: number experiencing 24 weeks · people with hip or knee osteoarthritis

Liver toxicity: number experiencing abnormal liver function tests 24 weeks · people with hip or knee osteoarthritis

Serious adverse events: number experiencing 24 weeks · people with hip or knee osteoarthritis

HRQL FIQ Total. Scale from 0 to 100; high scores indicate worse quality of life Median length of interventions: 12 weeks · individuals with fibromyalgia

Pain FIQ Pain, VAS, and SF‐36 Bodily Pain. Scale from 0 to 100; high scores indicate worse pain Median length of interventions: 12 weeks · individuals with fibromyalgia

Fatigue FIQ Fatigue, VAS, and SF‐36 vitality. Scale from 0 to 100; high scores indicate worse fatigue Median length of interventions: 16 weeks · individuals with fibromyalgia

Stiffness FIQ Stiffness and VAS. Scale from: 0 to 100; high scores indicate worse stiffness Median length of interventions: 12 weeks · individuals with fibromyalgia

Physical function FIQ Physical Function, SF‐36 Physical Function, AIMS, and HAQ. Scale converted to 0 to 100; high scores indicate worse physical function Median length of interventions: 12 weeks · individuals with fibromyalgia

All‐cause withdrawal All‐cause withdrawals from studies Median length of interventions: 16 weeks · individuals with fibromyalgia

Adverse events ‐ increase in symptoms, injuries, or serious adverse events · individuals with fibromyalgia

Health‐related quality of life · adults with fibromyalgia

Pain intensity · adults with fibromyalgia

Fatigue · adults with fibromyalgia

Stiffness · adults with fibromyalgia

Physical function · adults with fibromyalgia